Novel diagnostic approaches and cost-benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: lessons from the 15th Turin Congress on Immune Pathology and Orphan Disease.

Authors
Publication date
1 January 2013
Publisher
'Elsevier BV'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Institutional Research Information System University of Turin

      redirect
      oaioai:iris.unito.it:2318/144928
      Last time updated on 18/04/2020

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fj.autrev.20...
      Last time updated on 05/01/2021